Literature DB >> 34853063

Atrasentan: The Difficult Task of Integrating Endothelin A Receptor Antagonists into Current Treatment Paradigm for Diabetic Kidney Disease.

Alberto Ortiz1,2, Beatriz Fernandez-Fernandez3,2.   

Abstract

Entities:  

Keywords:  albuminuria; atrasentan; diabetic nephropathy; endothelin A receptor antagonists

Year:  2021        PMID： 34853063      PMCID： PMC8729503          DOI： 10.2215/CJN.13601021

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Authors:  Vlado Perkovic; Meg J Jardine; Bruce Neal; Severine Bompoint; Hiddo J L Heerspink; David M Charytan; Robert Edwards; Rajiv Agarwal; George Bakris; Scott Bull; Christopher P Cannon; George Capuano; Pei-Ling Chu; Dick de Zeeuw; Tom Greene; Adeera Levin; Carol Pollock; David C Wheeler; Yshai Yavin; Hong Zhang; Bernard Zinman; Gary Meininger; Barry M Brenner; Kenneth W Mahaffey
Journal:  N Engl J Med       Date:  2019-04-14       Impact factor: 91.245

2.  Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Authors:  Hiddo J L Heerspink; Hans-Henrik Parving; Dennis L Andress; George Bakris; Ricardo Correa-Rotter; Fan-Fan Hou; Dalane W Kitzman; Donald Kohan; Hirofumi Makino; John J V McMurray; Joel Z Melnick; Michael G Miller; Pablo E Pergola; Vlado Perkovic; Sheldon Tobe; Tingting Yi; Melissa Wigderson; Dick de Zeeuw
Journal:  Lancet       Date:  2019-04-14       Impact factor: 79.321

3.  The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A Post Hoc Analysis of the SONAR Randomized Trial.

Authors:  Simke W Waijer; Ron T Gansevoort; George L Bakris; Ricardo Correa-Rotter; Fan-Fan Hou; Donald E Kohan; Dalane W Kitzman; Hirofumi Makino; John J V McMurray; Vlado Perkovic; Sheldon Tobe; Hans-Henrik Parving; Dick de Zeeuw; Hiddo J L Heerspink
Journal:  Clin J Am Soc Nephrol       Date:  2021-12-01       Impact factor: 8.237

4.  Dapagliflozin in Patients with Chronic Kidney Disease.

Authors:  Hiddo J L Heerspink; Bergur V Stefánsson; Ricardo Correa-Rotter; Glenn M Chertow; Tom Greene; Fan-Fan Hou; Johannes F E Mann; John J V McMurray; Magnus Lindberg; Peter Rossing; C David Sjöström; Roberto D Toto; Anna-Maria Langkilde; David C Wheeler
Journal:  N Engl J Med       Date:  2020-09-24       Impact factor: 91.245

5.  New insights from SONAR indicate adding sodium glucose co-transporter 2 inhibitors to an endothelin receptor antagonist mitigates fluid retention and enhances albuminuria reduction.

Authors:  Hiddo J L Heerspink; Donald E Kohan; Dick de Zeeuw
Journal:  Kidney Int       Date:  2020-11-02       Impact factor: 10.612

6.  Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.

Authors:  George L Bakris; Rajiv Agarwal; Stefan D Anker; Bertram Pitt; Luis M Ruilope; Peter Rossing; Peter Kolkhof; Christina Nowack; Patrick Schloemer; Amer Joseph; Gerasimos Filippatos
Journal:  N Engl J Med       Date:  2020-10-23       Impact factor: 91.245

7.  Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

Authors:  Beatriz Fernandez-Fernandez; Raul Fernandez-Prado; Jose Luis Górriz; Alberto Martinez-Castelao; Juan F Navarro-González; Esteban Porrini; María José Soler; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2019-05-31

8.  Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis.

Authors:  Meg Jardine; Zien Zhou; Hiddo J Lambers Heerspink; Carinna Hockham; Qiang Li; Rajiv Agarwal; George L Bakris; Christopher P Cannon; David M Charytan; Tom Greene; Adeera Levin; Jing-Wei Li; Brendon L Neuen; Bruce Neal; Richard Oh; Megumi Oshima; Carol Pollock; David C Wheeler; Dick de Zeeuw; Hong Zhang; Bernard Zinman; Kenneth W Mahaffey; Vlado Perkovic
Journal:  Clin J Am Soc Nephrol       Date:  2021-02-22       Impact factor: 8.237

Review 9.  Fighting the unbearable lightness of neglecting kidney health: the decade of the kidney.

Authors:  Raymond Vanholder; Lieven Annemans; Aminu K Bello; Boris Bikbov; Daniel Gallego; Ron T Gansevoort; Norbert Lameire; Valerie A Luyckx; Edita Noruisiene; Tom Oostrom; Christoph Wanner; Fokko Wieringa
Journal:  Clin Kidney J       Date:  2021-04-20

10.  Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.

Authors:  Glenn M Chertow; Priya Vart; Niels Jongs; Robert D Toto; Jose Luis Gorriz; Fan Fan Hou; John J V McMurray; Ricardo Correa-Rotter; Peter Rossing; C David Sjöström; Bergur V Stefánsson; Anna Maria Langkilde; David C Wheeler; Hiddo J L Heerspink
Journal:  J Am Soc Nephrol       Date:  2021-07-16       Impact factor: 14.978
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.